Ignite Creation Date:
2025-12-24 @ 5:58 PM
Ignite Modification Date:
2025-12-29 @ 10:30 AM
Study NCT ID:
NCT00818168
Status:
COMPLETED
Last Update Posted:
2015-09-03
First Post:
2009-01-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Remicade Safety Line (Ankylosing Spondylitis)(Study P03275)(COMPLETED)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-07
Start Date Type:
None
Primary Completion Date:
2010-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-12
Completion Date Type:
ACTUAL
First Submit Date:
2009-01-06
First Submit QC Date:
None
Study First Post Date:
2009-01-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-12-22
Results First Submit QC Date:
None
Results First Post Date:
2012-02-01
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-09-02
Last Update Post Date:
2015-09-03
Last Update Post Date Type:
ESTIMATED